| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 1.2K | 3.4% | 24.5% |
| Total Income | 1.2K | 4.6% | 25.3% |
| Expenditure | 1.0K | 2.2% | 30.8% |
| PBT | 187.28 | 56.4% | 40.4% |
| Net Profit | 141.65 | 49.1% | 39.7% |
| OPM | 21.03% | 4.91pp | 2.26pp |
| NPM | 11.85% | 3.53pp | 1.23pp |
| EPS | 5.36 | 51.4% | 42.2% |
Global Health FY26: Total Income Up 19.6% YoY to ₹45,089 Mn
14 May 2026 · 14 May, 6:52 pm
Summary
Global Health Limited announced strong financial results for the fourth quarter and full year ended March 31, 2026. For FY2026, consolidated total income grew by 19.6% year-over-year to ₹45,089 million, with Profit After Tax rising 15.1% to ₹5,541 million. The fourth quarter also demonstrated robust performance, achieving the highest ever quarterly total income of ₹11,958 million, up 25.3% year-over-year, and a significant 39.7% increase in Profit After Tax to ₹1,417 million. Margins for Q4 FY26 saw improvement, with PAT margins reaching 11.8% and EBITDA (ex-Noida) margins at 27.5%. Management highlighted strong execution, higher patient volumes, and successful operationalization of the Noida hospital as key drivers for the positive performance.
Key Highlights
- 1
Consolidated Total Income for FY2026 reached ₹45,089 million, marking a strong growth of 19.6% year-over-year.
- 2
Profit After Tax for FY2026 increased by 15.1% year-over-year to ₹5,541 million.
- 3
The company reported its highest ever quarterly total income in Q4 FY2026 at ₹11,958 million, representing a 25.3% year-over-year growth.
- 4
Q4 FY2026 Profit After Tax saw robust growth of 39.7% year-over-year, reaching ₹1,417 million, with PAT margins improving to 11.8% from 10.6% in Q4 FY25.
- 5
EBITDA (excluding Noida) for FY2026 grew by 18.6% year-over-year to ₹11,343 million, achieving margins of 25.7%.
- 6
Total bed capacity expanded by 20.5% year-over-year in FY26, with the addition of 623 beds, including 382 beds at the newly operational Medanta Noida.
Management Comments
Pankaj Sahni
FY2026 marked another year of strong execution for Medanta, with robust operational and financial performance across the network. Growth was driven by higher patient volumes, improved realizations, and consistent delivery across our hospitals. During the year, we successfully operationalized our 550-bed Noida hospital, which achieved NABH accreditation within the first six months, underscoring the strength of our institutional systems and clinical protocols. The facility is now fully operational, supported by 200+ clinicians, 382 beds, 14 operating theatres, and advanced medical technologies. The ramp-up is progressing well and is increasingly reflected in our financial performance.
Informational and educational content only. Not investment advice.